Skip to main content
Premium Trial:

Request an Annual Quote

Microbial Boost?

Two studies plan to evaluate whether swabbing babies born via caesarian section with their mothers' microbes will boost their own microbiome and prevent disease, NPR reports.

One of the studies is taking place at the Inova hospital system and, there, researchers led by Suchitra Hourigan, a pediatric gastroenterologist, will first swab 50 babies, half with their mothers' birth canal microbiomes and half with a sterile solution, in a procedure known as vaginal seeding, NPR adds. If safe, then they plan to boost their cohort size to 800. The other study is to take place at the Icahn School of Medicine at Mount Sinai.

The thought, NPR notes, it that the procedure will lead to the microbiomes of these C-section babies to develop more like those of their vaginally delivered counterparts. And, as the number of C-section have risen around the same time as asthma, allergies, obesity, and other diseases, it may potentially cut down on disease risk as well.

"Who knows what's going to happen with the results? But if it does show something positive, I just think that would be great for kids and parents," Danielle Vukadinovich, an Inova study participant, tells NPR.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.